Jense Panse

39PUBLICATIONS
245CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Nov 05, 2026
Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm.

|Oct 08, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.

|Sep 24, 2026
Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity.

|Aug 18, 2026
Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial.

|Jul 10, 2026
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study.

|Jul 03, 2026
A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified.

Pageof 7

Frequent Collaborators

7 joint publications

Johannes Lübke

6 joint publications

Martin Schmidt-Hieber

5 joint publications

Jan-Hendrik Naendrup

5 joint publications

Peter Valent